Estimation of serum and tissue level of interleukin‐15 (IL‐15) and IL‐15 receptor alpha (IL‐15Rα) in mycosis fungoides before and after phototherapy: An interventional cohort study
Photodermatology, Photoimmunology & Photomedicine · 2024
DOI: 10.1111/phpp.12938 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Photodermatology, Photoimmunology & Photomedicine, 2024. Verfasst von Rania M Mogawer und 5 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology Department, Faculty of Medicine, Cairo University, Cairo, Egypt. Hauptthemen laut MEDLINE: Skin Neoplasms, Mycosis Fungoides, Lymphoma, T-Cell, Cutaneous. Die Arbeit nennt 26 Literaturangaben.
Abstract (Originalsprache)
Background
Mycosis fungoides (MF) is a chronic, highly recurrent cutaneous T‐cell lymphoma, whose pathogenesis has not yet been fully elucidated. Interleukin‐15 was previously highlighted as a viability factor for cutaneous T‐cell lymphoma with previous studies shedding light on its role in pathogenesis of MF and its plausibility as a potential therapeutic target.
Objective
This study was conducted to evaluate serum and tissue expression of IL‐15 and IL‐15Rα in early cases of MF (IA, IB, IIA) at baseline and following phototherapy. Materials and Methods Fourteen early MF cases were recruited. Samples were withdrawn prior to starting phototherapy treatment and following near complete clearance of the biopsied lesion or after a maximum of 36 sessions of phototherapy. Samples were assessed for change in expression of IL‐15 and IL‐15 Rα levels following treatment, whose levels were compared to healthy controls.
Results
Serum and tissue levels of IL‐15 and IL‐15Rα in early MF cases were significantly higher at baseline than their levels following phototherapy treatment and higher than healthy controls. However, they dropped significantly following treatment with no statistical difference between treated cases and controls, apart from serum IL‐15Rα that remained significantly elevated than controls.
Conclusion
Interleukin‐15 and its receptor alpha appear to contribute to the pathogenesis of MF, being significantly elevated than healthy controls, which were normalized following phototherapy treatment, apart from serum IL‐15Rα, which remained elevated. Controlling IL‐15/IL‐15Rα expression is a newly proposed mechanism of action of phototherapy in MF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Dermatology Department, Faculty of Medicine, Cairo University, Cairo, Egypt.
- Biochemistry Department, Faculty of Medicine, Cairo University, Cairo, Egypt.
ORCID-Profile: Rania M Mogawer
Zitieren
APA
Mogawer, R. M., Youssef, R., Helmy, K., Emad, N., Shaker, O., & Orabi, S. (2024). Estimation of serum and tissue level of interleukin‐15 (IL‐15) and IL‐15 receptor alpha (IL‐15Rα) in mycosis fungoides before and after phototherapy: An interventional cohort study. Photodermatology, Photoimmunology & Photomedicine. https://doi.org/10.1111/phpp.12938
Vancouver
Mogawer RM, Youssef R, Helmy K, Emad N, Shaker O, Orabi S. Estimation of serum and tissue level of interleukin‐15 (IL‐15) and IL‐15 receptor alpha (IL‐15Rα) in mycosis fungoides before and after phototherapy: An interventional cohort study. Photodermatology, Photoimmunology & Photomedicine. 2024. doi:10.1111/phpp.12938
BibTeX
@article{Mogawer2024,
author = {Mogawer, Rania M and Youssef, Randa and Helmy, Kholoud and Emad, Nourhan and Shaker, Olfat and Orabi, Sarah},
title = {Estimation of serum and tissue level of interleukin‐15 (IL‐15) and IL‐15 receptor alpha (IL‐15Rα) in mycosis fungoides before and after phototherapy: An interventional cohort study},
journal = {Photodermatology, Photoimmunology & Photomedicine},
year = {2024},
doi = {10.1111/phpp.12938}
}
EUVIMED